Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MT-110 by Myosin Therapeutics for Substance (Drug) Abuse: Likelihood of Approval
MT-110 is under clinical development by Myosin Therapeutics and currently in Phase I for Substance (Drug) Abuse. According to GlobalData,...